441 related articles for article (PubMed ID: 18073481)
1. Oxidized low-density lipoproteins, autoantibodies against oxidized low-density lipoproteins and carotid intima media thickness in a clinically healthy population.
Chen HW; Kuo CL; Huang CS; Kuo SJ; Liu CS
Cardiology; 2008; 110(4):252-9. PubMed ID: 18073481
[TBL] [Abstract][Full Text] [Related]
2. Oxidized low-density lipoprotein autoantibodies, chronic infections, and carotid atherosclerosis in a population-based study.
Mayr M; Kiechl S; Tsimikas S; Miller E; Sheldon J; Willeit J; Witztum JL; Xu Q
J Am Coll Cardiol; 2006 Jun; 47(12):2436-43. PubMed ID: 16781371
[TBL] [Abstract][Full Text] [Related]
3. Relations between autoantibodies against oxidized low-density lipoprotein, inflammation, subclinical atherosclerosis, and cardiovascular disease in rheumatoid arthritis.
Peters MJ; van Halm VP; Nurmohamed MT; Damoiseaux J; Tervaert JW; Twisk JW; Dijkmans BA; Voskuyl AE
J Rheumatol; 2008 Aug; 35(8):1495-9. PubMed ID: 18597411
[TBL] [Abstract][Full Text] [Related]
4. Oxidized low-density lipoproteins and their antibodies: relationships with the reverse cholesterol transport and carotid atherosclerosis in adults without cardiovascular diseases.
Ferreira PF; Zago VH; D'Alexandri FL; Panzoldo NB; Gidlund MA; Nakamura RT; Schreiber R; Parra ES; Santiago FD; Nakandakare ER; Quintão EC; de Faria EC
Clin Chim Acta; 2012 Oct; 413(19-20):1472-8. PubMed ID: 22659061
[TBL] [Abstract][Full Text] [Related]
5. Association between human paraoxonase 1 activity and intima-media thickness in subjects under 55 years of age with carotid artery disease.
Harangi M; Seres I; Magyar MT; Csipo I; Sipka S; Valikovics A; Csiba L; Bereczki D; Paragh G
Cerebrovasc Dis; 2008; 25(1-2):122-8. PubMed ID: 18073465
[TBL] [Abstract][Full Text] [Related]
6. Oxidized low-density lipoprotein in plasma is a prognostic marker of subclinical atherosclerosis development in clinically healthy men.
Wallenfeldt K; Fagerberg B; Wikstrand J; Hulthe J
J Intern Med; 2004 Nov; 256(5):413-20. PubMed ID: 15485477
[TBL] [Abstract][Full Text] [Related]
7. Antibodies against various forms of mildly oxidized low-density lipoprotein are not associated with carotid intima-media thickness in patients with primary hyperlipidemia.
Tsouli SG; Kiortsis DN; Xydis V; Argyropoulou MI; Elisaf M; Tselepis AD
Angiology; 2006; 57(5):615-22. PubMed ID: 17067985
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies against oxidized low-density lipoprotein (LDL) and carotid atherosclerosis in patients with rheumatoid arthritis.
Wada Y; Kuroda T; Murasawa A; Tanabe N; Nakano M; Gejyo F
Clin Exp Rheumatol; 2005; 23(4):482-6. PubMed ID: 16095116
[TBL] [Abstract][Full Text] [Related]
9. Plasma interleukin-5 levels are related to antibodies binding to oxidized low-density lipoprotein and to decreased subclinical atherosclerosis.
Sämpi M; Ukkola O; Päivänsalo M; Kesäniemi YA; Binder CJ; Hörkkö S
J Am Coll Cardiol; 2008 Oct; 52(17):1370-8. PubMed ID: 18940525
[TBL] [Abstract][Full Text] [Related]
10. Antibodies against oxidized LDL and carotid artery intima-media thickness in a healthy population.
Fukumoto M; Shoji T; Emoto M; Kawagishi T; Okuno Y; Nishizawa Y
Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):703-7. PubMed ID: 10712394
[TBL] [Abstract][Full Text] [Related]
11. Oxidized LDL to autoantibodies against oxLDL ratio - the new biomarker associated with carotid atherosclerosis and cardiovascular complications in dialyzed patients.
Pawlak K; Mysliwiec M; Pawlak D
Atherosclerosis; 2012 Sep; 224(1):252-7. PubMed ID: 22840691
[TBL] [Abstract][Full Text] [Related]
12. High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation.
Santos AO; Fonseca FA; Fischer SM; Monteiro CM; Brandão SA; Póvoa RM; Bombig MT; Carvalho AC; Monteiro AM; Ramos E; Gidlund M; Figueiredo Neto AM; Izar MC
Clin Chim Acta; 2009 Aug; 406(1-2):113-8. PubMed ID: 19523463
[TBL] [Abstract][Full Text] [Related]
13. Antibodies against human oxidized low-density lipoprotein (LDL) as markers for human plasma modified lipoproteins.
Radulescu L; Stancu C; Antohe F
Med Sci Monit; 2004 Jul; 10(7):BR207-14. PubMed ID: 15232494
[TBL] [Abstract][Full Text] [Related]
14. Elevated peroxidative glutathione redox status in atherosclerotic patients with increased thickness of carotid intima media.
Huang YS; Wang LX; Sun L; Wu Y; Lu JM; Zhao SC; Dai FM; Xu BS; Wang SR
Chin Med J (Engl); 2009 Dec; 122(23):2827-32. PubMed ID: 20092785
[TBL] [Abstract][Full Text] [Related]
15. Intima-media thickness of carotid artery and susceptibility to atherosclerosis in obese children with nonalcoholic fatty liver disease.
Demircioğlu F; Koçyiğit A; Arslan N; Cakmakçi H; Hizli S; Sedat AT
J Pediatr Gastroenterol Nutr; 2008 Jul; 47(1):68-75. PubMed ID: 18607271
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies against oxidized LDLs and atherosclerosis in type 2 diabetes.
Piarulli F; Lapolla A; Sartore G; Rossetti C; Bax G; Noale M; Minicuci N; Fiore C; Marchioro L; Manzato E; Fedele D
Diabetes Care; 2005 Mar; 28(3):653-7. PubMed ID: 15735203
[TBL] [Abstract][Full Text] [Related]
17. Augmentation index and carotid intima-media thickness are differently related to age, C-reactive protein and oxidized low-density lipoprotein.
Kampus P; Kals J; Ristimäe T; Muda P; Ulst K; Zilmer K; Salonen RM; Tuomainen TP; Teesalu R; Zilmer M
J Hypertens; 2007 Apr; 25(4):819-25. PubMed ID: 17351374
[TBL] [Abstract][Full Text] [Related]
18. Thickened carotid artery intima-media in rheumatoid arthritis is associated with elevated anticardiolipin antibodies.
Sherer Y; Gerli R; Gilburd B; Bartoloni Bocci E; Vaudo G; Mannarino E; Shoenfeld Y
Lupus; 2007; 16(4):259-64. PubMed ID: 17439932
[TBL] [Abstract][Full Text] [Related]
19. Oxidized LDL and anti-oxLDL antibody levels in peripheral atherosclerotic disease.
Andican G; Seven A; Uncu M; Cantaşdemir M; Numan F; Burçak G
Scand J Clin Lab Invest; 2008; 68(6):473-8. PubMed ID: 18609113
[TBL] [Abstract][Full Text] [Related]
20. Measurement of plasma ox-LDL and carotid IMT may represent useful markers for atherosclerosis and may represent potential targets for therapeutic interventions.
Savoiu G; Drăgan S; Cristescu C; Serban C; Noveanus L; Ionescu D; Nicola T; Duicu O; Raducan A; Voicu M
Rev Med Chir Soc Med Nat Iasi; 2009; 113(2):397-401. PubMed ID: 21491821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
